Perbedaan H.M. Sampoerna Tbk. dan Indofarma Tbk.: H.M. Sampoerna Tbk. diperdagangkan di Rp730 (kapitalisasi pasar 86,08 T, volume 24 jam 6,17 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: H.M. Sampoerna Tbk. jauh lebih besar — sekitar 220,4× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HMSP | INAF | |
|---|---|---|
Kapitalisasi Pasar | 86,08 T | 390,51 M |
Volume | 6,17 jt | — |
Lot | 61,7 rb | — |
Perputaran | 4,52 M | — |
Harga Rata-rata | 732,19 | — |
Nilai Transaksi | 4,52 M | — |
Harga Ekuilibrium Indikatif | 730 | — |
Volume Ekuilibrium Indikatif | 3,68 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Selengkapnya di halaman HMSP →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →